Bleeding events among patients concomitantly treated with direct oral anticoagulants and macrolide or fluoroquinolone antibiotics

Fluoroquinolones and macrolides may, due to a potential drug‐drug interaction, increase the concentration of any concomitantly administered direct oral anticoagulant (DOAC) and thereby increase the risk of severe bleeding. However, clinical evidence for such an effect is scarce. The present study ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagi, Tatsuya, Mannheimer, Buster, Reutfors, Johan, Ursing, Johan, Giunta, Diego Hernan, Kieler, Helle, Linder, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092847/
https://www.ncbi.nlm.nih.gov/pubmed/36098510
http://dx.doi.org/10.1111/bcp.15531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10092847/
https://www.ncbi.nlm.nih.gov/pubmed/36098510
http://dx.doi.org/10.1111/bcp.15531

Ejemplares similares